Faga Daniel

President, CEO at ANAB; EVP, Chief Operating Officer at Mirati Therapeutics, Inc.; Chief Business Officer at Spark Therapeutics, Inc.

Sold, on record
$9.4M
Dollars the filings state
Form 4 sales
15
Latest Mar 27, 2026
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
4
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Mirati Therapeutics, Inc.Plan not stated
    Jan 7, 2021 2021

    Sold 2,625 shares at $216.33 ($568k)

    Faga Daniel, EVP, Chief Operating Officer

    Sold 10% of holdings ($5.7M position)23,615 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Mirati Therapeutics, Inc.Plan not stated
    Feb 2, 2021 +26 days

    Sold 1,340 shares at $194.38 ($260k)

    Faga Daniel, EVP, Chief Operating Officer

    Sold 4.2% of holdings ($6.2M position)30,638 shares leftFiling

  3. 3 Form 4 sale ANABNo plan
    Jan 8, 2024 +1070 days

    Sold 6,866 shares at $21.81 ($150k)

    Faga Daniel, CEO

    No 10b5-1 planSold 0.8% of holdings ($19.7M position)898,027 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale ANABNo plan
    Mar 25, 2024 +77 days

    Sold 148,940 shares at $22.75 ($3.4M)

    Faga Daniel, CEO

    No 10b5-1 planSold 16.6% of holdings ($20.4M position)749,087 shares leftFiling

  5. 5 Form 4 sale ANABNo plan
    Jan 5, 2026 +651 days

    Sold 15,309 shares at $43.26 ($662k)

    Faga Daniel, President, CEO

    No 10b5-1 planSold 3.2% of holdings ($20.5M position)458,139 shares leftFiling

  6. 6 Form 4 sale ANABNo plan
    Jan 7, 2026 +2 days

    Sold 9,202 shares at $45.11 ($415k)

    Faga Daniel, President, CEO

    No 10b5-1 planSold 1.9% of holdings ($21.5M position)466,787 shares left0.6x usual sizeFiling

  7. 7 Form 4 sale ANABNo plan
    Jan 8, 2026 +1 day

    Sold 14,281 shares at $44.71 ($639k)

    Faga Daniel, President, CEO

    No 10b5-1 planSold 2.9% of holdings ($22.1M position)479,344 shares left0.9x usual sizeFiling

  8. 8 Form 4 sale ANABNo plan
    Mar 27, 2026 +78 days

    Sold 17,679 shares at $61.61 ($1.1M)

    Faga Daniel, President, CEO

    No 10b5-1 planSold 3.4% of holdings ($31.6M position)495,965 shares left1.2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (15)

Form 144 notices and Form 4 sales by Faga Daniel
Source
Mar 27, 2026Mar 27, 2026ANABPresident, CEOForm 4 sale17,679$1.1M3.4%No planSEC
Jan 8, 2026Jan 9, 2026ANABPresident, CEOForm 4 sale14,281$639k2.9%No planSEC
Jan 7, 2026Jan 8, 2026ANABPresident, CEOForm 4 sale9,202$415k1.9%No planSEC
Jan 5, 2026Jan 6, 2026ANABPresident, CEOForm 4 sale15,309$662k3.2%No planSEC
Mar 25, 2024Mar 26, 2024ANABCEOForm 4 sale148,940$3.4M16.6%No planSEC
Jan 8, 2024Jan 9, 2024ANABCEOForm 4 sale6,866$150k0.8%No planSEC
Feb 2, 2021Feb 3, 2021Mirati Therapeutics, Inc.EVP, Chief Operating OfficerForm 4 sale1,340$260k4.2%Plan not statedSEC
Jan 7, 2021Jan 8, 2021Mirati Therapeutics, Inc.EVP, Chief Operating OfficerForm 4 sale2,625$568k10.0%Plan not statedSEC
Oct 24, 2017Oct 24, 2017Spark Therapeutics, Inc.Chief Business OfficerForm 4 sale7,500$607k100.0%UnusualSEC
Sep 19, 2017Sep 20, 2017Spark Therapeutics, Inc.Chief Business OfficerForm 4 sale1,500$128k100.0%UnusualSEC
Sep 12, 2017Sep 14, 2017Spark Therapeutics, Inc.Chief Business OfficerForm 4 sale6,000$495k100.0%UnusualSEC
Sep 7, 2017Sep 11, 2017Spark Therapeutics, Inc.Chief Business OfficerForm 4 sale3,000$255k100.0%UnusualSEC
Jul 24, 2017Jul 26, 2017Spark Therapeutics, Inc.Chief Business OfficerForm 4 sale3,000$210k100.0%UnusualSEC
Jun 29, 2017Jun 29, 2017Spark Therapeutics, Inc.Chief Business OfficerForm 4 sale4,500$282k100.0%UnusualSEC
May 15, 2017May 17, 2017Spark Therapeutics, Inc.Chief Business OfficerForm 4 sale4,500$256k100.0%UnusualSEC